Clinical trial NCT00000485 - References

Hypertension — Hypertension Detection and Follow-up Program (HDFP)

Citation(s)

•   Abernethy J, Borhani NO, Hawkins CM, Crow R, Entwisle G, Jones JW, Maxwell MH, Langford H, Pressel S
  Systolic blood pressure as an independent predictor of mortality in the Hypertension Detection and Follow-up Program. Am J Prev Med. 1986 May-Jun;2(3):123-32.
•   Apostolides A, Hebel JR, McDill MS, Henderson MM
  High blood pressure: its care and consequences in urban centres. Int J Epidemiol. 1974 Jun;3(2):105-18.
•   Apostolides AY, Cutter G, Daugherty SA, Detels R, Kraus J, Wassertheil-Smoller S, Ware J
  Three-year incidence of hypertension in thirteen U.S. communities. On behalf of the Hypertension Detection and Follow-up Program cooperative group. Prev Med. 1982 Sep;11(5):487-99.
•   Apostolides AY, Cutter G, Kraus JF, Oberman A, Blaszkowski T, Borhani NO, Entwisle G
  Impact of hypertension information on high blood pressure control between 1973 and 1978. Hypertension. 1980 Sep-Oct;2(5):708-13.
•   Apostolides AY, Entwisle G, Ouellet R, Hebel JR
  Improving trend in hypertension control in a black inner city community. Am J Epidemiol. 1978 Feb;107(2):113-9.
•   Bell RL, Curb JD, Friedman LM, Payne GH
  Termination of clinical trials: the beta-blocker heart attack trial and the hypertension detection and follow-up program experience. Control Clin Trials. 1985 Jun;6(2):102-11.
•   Blaufox MD, Wassertheil-Smoller S
  Improving blood pressure normalization. Follow-up of hypertension screening and methodologies. N Y State J Med. 1979 Feb;79(2):231-5.
•   Blood pressure studies in 14 communities
  A two-stage screen for hypertension. JAMA. 1977 May 30;237(22):2385-91.
•   Blood Pressure Studies in l4 Communities: A Two-Stage Screen for Hypertension
  l978 Year Book of Cardiology: 355-57 (Summary of Mainstream Paper #2.)
•   Borhani N: The Hypertension Detection and Follow-Up Program, in Onesti G and Klimt C (eds), Hypertension
  Determinants, Complications, and Intervention, Grune & Stratton, New York, pp. 405-4l4, l979.
•   Borhani NO, Blaufox MD, Oberman A, Polk BF
  Incidence of coronary heart disease and left ventricular hypertrophy in the Hypertension Detection and Follow-up Program. Prog Cardiovasc Dis. 1986 Nov-Dec;29(3 Suppl 1):55-62.
•   Borhani NO: Clinical Ramifications of the Hypertension Detection and Follow-up Program: SC Yields Lower Mortality and Morbidity
  Symposia Reporter, 4(2):l6, May l980.
•   Cooper SP, Hardy RJ, Labarthe DR, Hawkins CM, Smith EO, Blaufox MD, Cooper CJ, Entwisle G, Maxwell MH
  The relation between degree of blood pressure reduction and mortality among hypertensives in the Hypertension Detection and Follow-Up Program. Am J Epidemiol. 1988 Feb;127(2):387-403.
•   Cowan L, Detels R, Farber M, Lee ES, McCray G, O'Flynn S, Parnell MJ
  Residential mobility and long-term treatment of hypertension. J Community Health. 1980 Spring;5(3):159-66.
•   Cressman MD, Gifford RW Jr
  Clinicians' interpretation of the results and implications of the Hypertension Detection and Follow-up Program. Prog Cardiovasc Dis. 1986 Nov-Dec;29(3 Suppl 1):89-97.
•   Curb JD, Borhani NO, Blaszkowski TP, Zimbaldi N, Fotiu S, Williams W
  Long-term surveillance for adverse effects of antihypertensive drugs. JAMA. 1985 Jun 14;253(22):3263-8.
•   Curb JD, Borhani NO, Blaszkowski TP, Zimbaldi N, Fotiu S, Williams W
  Patient-perceived side effects to antihypertensive drugs. Am J Prev Med. 1985 Jan-Feb;1(1):36-40.
•   Curb JD, Ford C, Hawkins CM, Smith EO, Zimbaldi N, Carter B, Cooper C
  A coordinating center in a clinical trial: the Hypertension Detection and Followup Program. Control Clin Trials. 1983 Sep;4(3):171-86.
•   Curb JD, Hardy RJ, Labarthe DR, Borhani NO, Taylor JO
  Reserpine and breast cancer in the Hypertension Detection and Follow-Up Program. Hypertension. 1982 Mar-Apr;4(2):307-11.
•   Curb JD, Maxwell MH, Schneider KA, Taylor JO, Shulman NB
  Adverse effects of antihypertensive medications in the Hypertension Detection and Follow-up Program. Prog Cardiovasc Dis. 1986 Nov-Dec;29(3 Suppl 1):73-88. Review.
•   Curb JD, Schneider K, Taylor JO, Maxwell M, Shulman N
  Antihypertensive drug side effects in the Hypertension Detection and Follow-up Program. Hypertension. 1988 Mar;11(3 Pt 2):II51-5.
•   Cutter G, Heyden S, Kasteler J, Kraus JF, Lee ES, Shipley T, Stromer M
  Mortality surveillance in collaborative trials. Am J Public Health. 1980 Apr;70(4):394-400.
•   Daugherty SA, Berman R, Entwisle G, Haerer AF
  Cerebrovascular events in the Hypertension Detection and Follow-up Program. Prog Cardiovasc Dis. 1986 Nov-Dec;29(3 Suppl 1):63-72.
•   Daugherty SA
  Hypertension detection and follow-up program. Description of the enumerated and screened population. Hypertension. 1983 Nov-Dec;5(6 Pt 2):IV1-43.
•   Daugherty SA
  Mortality findings beyond five years in the hypertension detection and follow-up program (HDFP). J Hypertens Suppl. 1988 Dec;6(4):S597-601.
•   Davis BR, Curb JD, Borhani NO, Prineas RJ, Molteni A
  Coffee consumption and serum cholesterol in the hypertension detection and follow-up program. Am J Epidemiol. 1988 Jul;128(1):124-36.
•   Davis BR, Ford CE, Remington RD, Stamler R, Hawkins CM
  The Hypertension Detection and Follow-up Program design, methods, and baseline characteristics and blood pressure response of the study population. Prog Cardiovasc Dis. 1986 Nov-Dec;29(3 Suppl 1):11-28.
•   Davis BR, Langford HG, Blaufox MD, Curb JD, Polk BF, Shulman NB
  The association of postural changes in systolic blood pressure and mortality in persons with hypertension: the Hypertension Detection and Follow-up Program experience. Circulation. 1987 Feb;75(2):340-6.
•   Educational level and 5-year all-cause mortality in the Hypertension Detection and Follow-up Program
  Hypertension Detection and Follow-up Program Cooperative Group. Hypertension. 1987 Jun;9(6):641-6.
•   Effect of stepped care treatment on the incidence of myocardial infarction and angina pectoris
  5-Year findings of the hypertension detection and follow-up program. Hypertension. 1984 Mar-Apr;6(2 Pt 2):I198-206.
•   Entwisle G, Apostolides AY, Hebel JR, Henderson MM
  Target organ damage in black hypertensives. Circulation. 1977 May;55(5):792-6.
•   Finnerty FA Jr, Shaw LW, Himmelsbach CK
  Hypertension in the inner city. II. Detection and follow-up. Circulation. 1973 Jan;47(1):76-8.
•   Five-year findings of the hypertension detection and follow-up program
  I. Reduction in mortality of persons with high blood pressure, including mild hypertension. Hypertension Detection and Follow-up Program Cooperative Group. JAMA. 1979 Dec 7;242(23):2562-71.
•   Five-year findings of the hypertension detection and follow-up program
  II. Mortality by race-sex and age. Hypertension Detection and Follow-up Program Cooperative Group. JAMA. 1979 Dec 7;242(23):2572-7.
•   Five-year findings of the hypertension detection and follow-up program
  III. Reduction in stroke incidence among persons with high blood pressure. Hypertension Detection and Follow-up Program Cooperative Group. JAMA. 1982 Feb 5;247(5):633-8.
•   Five-year findings of the Hypertension Detection and Follow-up Program
  Prevention and reversal of left ventricular hypertrophy with antihypertensive drug therapy. Hypertension Detection and Follow-up Program Cooperative Group. Hypertension. 1985 Jan-Feb;7(1):105-12.
•   Five-year findings of the Hypertension Detection and Follow-up Program: mortality by race-sex and blood pressure level
  A further analysis. Hypertension Detection and Follow-up Program Cooperative Group. J Community Health. 1984 Summer;9(4):314-27.
•   Ford CE, Langford HG, Palmer MJ
  Recruitment in the hypertension detection and follow-up program. Control Clin Trials. 1987 Dec;8(4 Suppl):54S-67S.
•   Hardy RJ, Hawkins CM
  The impact of selected indices of antihypertensive treatment on all-cause mortality. Am J Epidemiol. 1983 May;117(5):566-74.
•   Harlan LC, Polk BF, Cooper S, Blaszkowski TP, Ignatius-Smith J, Stromer M, Mull H
  Effects of labeling and treatment of hypertension on perceived health. Am J Prev Med. 1986 Sep-Oct;2(5):256-61.
•   Henderson M, Apostolides A, Entwisle G, Hebel R
  A study of hypertension in a black urban community: preliminary epidemiologic findings. Prev Med. 1974 Sep;3(3):334-43.
•   Heyden S, Borhani NO, Tyroler HA, Schneider KA, Langford HG, Hames CG, Hutchinson R, Oberman A
  The relationship of weight change to changes in blood pressure, serum uric acid, cholesterol and glucose in the treatment of hypertension. J Chronic Dis. 1985;38(4):281-8.
•   Heyden S, Tyroler HA, Hames G, et al: Diet Treatment of Obese Hypertensives
  Clinical Science and Molecular Medicine, 45:2095-2125, 1973.
•   Hypertension and Education
  Journal of the American Dietetic Association, 72 (4):377, April l978. (Summary of Mainstream Paper #5A.)
•   Hypertension detection and follow-up program
  Baseline characteristics of the enumerated, screened, and hypertensive participants. The Hypertension Detection and Follow-up Program Cooperative Group. Hypertension. 1983 Nov-Dec;5(6 Pt 2):IV1-205.
•   Implications of the Hypertension Detection and Follow-up Program
  The Hypertension Detection and Follow-up Program Cooperative Group. Prog Cardiovasc Dis. 1986 Nov-Dec;29(3 Suppl 1):3-10.
•   Kraus JF, Conley A, Hardy R, Sexton M, Sweezy Z
  Relationship of demographic characteristics of interviewers to blood pressure measurements. J Community Health. 1982 Fall;8(1):3-12.
•   Kraus JF, Curb JD, Cutter G, Daugherty SA, Neill KC, Wassertheil-Smoller S
  Hypertension detection and follow-up program. Baseline medical history characteristics of the hypertensive participants. Hypertension. 1983 Nov-Dec;5(6 Pt 2):IV51-91.
•   Labarthe DR, Hawkins CM, Remington RD
  Evaluation of performance of selected devices for measuring blood pressure. Am J Cardiol. 1973 Sep 20;32(4):546-53.
•   Langford HG, Oberman A, Borhani NO, Entwisle G, Tung B
  Black-white comparison of indices of coronary heart disease and myocardial infarction in the stepped-care cohort of the Hypertension Detection and Follow-Up Program. Am Heart J. 1984 Sep;108(3 Pt 2):797-801.
•   Langford HG, Stamler J, Wassertheil-Smoller S, Prineas RJ
  All-cause mortality in the Hypertension Detection and Follow-up Program: findings for the whole cohort and for persons with less severe hypertension, with and without other traits related to risk of mortality. Prog Cardiovasc Dis. 1986 Nov-Dec;29(3 Suppl 1):29-54.
•   Langford HG, Watson RL, Thomas JG
  Salt intake and the treatment of hypertension. Am Heart J. 1977 Apr;93(4):531-2.
•   Langford HG
  Further analyses of the hypertension detection and follow-up program. Drugs. 1986;31 Suppl 1:23-8.
•   Langford HG: Clinical Ramifications of the Hypertension Detection and Follow-up Program: HDFP Methodology and Results: Overview
  Symposia Reporter, 4(2):3-6, May l980.
•   Lewin A, Blaufox MD, Castle H, Entwisle G, Langford H
  Apparent prevalence of curable hypertension in the Hypertension Detection and Follow-up Program. Arch Intern Med. 1985 Mar;145(3):424-7.
•   Martin JB, Annegers JF, Curb JD, Heyden S, Howson C, Lee ES, Lee M
  Mortality patterns among hypertensives by reported level of caffeine consumption. Prev Med. 1988 May;17(3):310-20.
•   Maxwell MH, Fitzsimmons E, Harrist R, Hotchkiss J, Langford HG, Payne GH, Schneider KA, Varaday P
  Hypertension detection and follow-up program. Baseline laboratory examination characteristics of the hypertensive participants. Hypertension. 1983 Nov-Dec;5(6 Pt 2):IV133-59.
•   Maxwell MH, Ford CE
  Cardiovascular morbidity and mortality in HDFP patients 50-69 years old at entry. J Cardiovasc Pharmacol. 1985;7 Suppl 2:S5-9.
•   Mild hypertensives in the hypertension detection and follow-up program
  The Hypertension Detection and Follow-up Cooperative Group. Ann N Y Acad Sci. 1978 Mar 30;304:254-66.
•   Morris DL, Borhani NO, Fitzsimons E, Hardy RJ, Hawkins CM, Kraus JF, Labarthe DR, Mastbaum L, Payne GH
  Serum cholesterol and cancer in the Hypertension Detection and Follow-up Program. Cancer. 1983 Nov 1;52(9):1754-9.
•   Mortality findings for stepped-care and referred-care participants in the hypertension detection and follow-up program, stratified by other risk factors
  The Hypertension Detection and Follow-up Program Cooperative Research Group. Prev Med. 1985 May;14(3):312-35.
•   Oberman A, Blaufox MD, Entwisle G, Harrist R
  Hypertension detection and follow-up program. Baseline chest radiographic characteristics of the hypertensive participants. Hypertension. 1983 Nov-Dec;5(6 Pt 2):IV190-200.
•   Ouellet RP, Apostolides AY, Entwisle G, Hebel JR
  Estimated community impact of hypertension control in a high risk population. Am J Epidemiol. 1979 May;109(5):531-8.
•   Patient participation in a hypertension control program
  Hypertension Detection and Follow-up Program Cooperative Group. JAMA. 1978 Apr 14;239(15):1507-14.
•   Persistence of reduction in blood pressure and mortality of participants in the Hypertension Detection and Follow-up Program
  Hypertension Detection and Follow-up Program Cooperative Group. JAMA. 1988 Apr 8;259(14):2113-22.
•   Polk BF, Cutter G, Daugherty RM, Gosch F, Heyden S, Shulman N, Tyroler HA
  Hypertension detection and follow-up program. Baseline physical examination characteristics of the hypertensive participants. Hypertension. 1983 Nov-Dec;5(6 Pt 2):IV92-132.
•   Polk BF, Harlan LC, Cooper SP, Stromer M, Ignatius J, Mull H, Blaszkowski TP
  Disability days associated with detection and treatment in a hypertension control program. Am J Epidemiol. 1984 Jan;119(1):44-53.
•   Prineas RJ, Castle CH, Curb JD, Harrist R, Lewin A, Stamler J
  Hypertension detection and follow-up program. Baseline electrocardiographic characteristics of the hypertensive participants. Hypertension. 1983 Nov-Dec;5(6 Pt 2):IV160-89.
•   Race, education and prevalence of hypertension
  Am J Epidemiol. 1977 Nov;106(5):351-61.
•   Remington RD On behalf of the HDFP Cooperative Group: The Hypertension Detection and Follow-up Program
  Inserm, 21:185-194, 1973.
•   Schlant RC, Felner JL, Heymsfield SB, Gilbert CA, Shulman NB, Tuttle EP, and Blumenstein BA: Echocardiography and Essential Hypertension
  Cardiovascular Medicine, 2:477-490, l977.
•   Shulman N, Cutter G, Daugherty R, Sexton M, Pauk G, Taylor MJ, Tyler M
  Correlates of attendance and compliance in the hypertension detection and follow-up program. Control Clin Trials. 1982 Mar;3(1):13-27.
•   Shulman NB, Ford CE, Hall WD, Blaufox MD, Simon D, Langford HG, Schneider KA
  Prognostic value of serum creatinine and effect of treatment of hypertension on renal function. Results from the hypertension detection and follow-up program. The Hypertension Detection and Follow-up Program Cooperative Group. Hypertension. 1989 May;13(5 Suppl):I80-93.
•   Smith EO, Curb JD, Hardy RJ, Hawkins CM, Tyroler HA
  Clinic attendance in the hypertension detection and follow-up program. Hypertension. 1982 Sep-Oct;4(5):710-5.
•   Smith EO, Hardy RJ, Cooper CJ, Hawkins CM
  Two-compartment Markov regression analysis. Comput Programs Biomed. 1980 Dec;12(2-3):129-40.
•   Smith EO, Hardy RJ, Cutter GR, Curb JD, and Hawkins CM: Application of Survival Analysis Techniques to Evaluation of Factors Affecting Compliance in a Clinical Trial of Hypertension Control
  Controlled Clin Trials, l:59-69, l980.
•   Smith EO, Hardy RJ, Cutter GR
  A two-compartment regression model applied to compliance in a hypertension treatment program. J Chronic Dis. 1980;33(10):645-51.
•   Stamler J, Borhani NO: Interview: HDFP Mortality and Morbidity
  Hypertension Report, 1(l):l2-l4, l980.
•   Stamler J: Clinical Ramifications of the Hypertension Detection and Follow-up Program: Benefits of Treatment Outweigh Risks
  Symposia Reporter, 4(2):l2-l4, May l980.
•   Stamler R, Ford CE, Stamler J
  Why do lean hypertensives have higher mortality rates than other hypertensives? Findings of the Hypertension Detection and Follow-up Program. Hypertension. 1991 Apr;17(4):553-64.
•   Stamler R, Gosch FC, Stamler J, Lindberg HA, Hilker RR
  A hypertension control program based on the workplace. Report on the Chicago Center. J Occup Med. 1978 Sep;20(9):618-25.
•   Taylor J
  The hypertension detection and follow-up program: a progress report. Circ Res. 1977 May;40(5 Suppl 1):I106-9.
•   Taylor JO, Borhani NO, Entwisle G, Farber M, Hawkins CM
  Hypertension detection and follow-up program. Summary of the baseline characteristics of the hypertensive participants. Hypertension. 1983 Nov-Dec;5(6 Pt 2):IV44-50.
•   The effect of antihypertensive drug treatment on mortality in the presence of resting electrocardiographic abnormalities at baseline: the HDFP experience
  The Hypertension Detection and Follow-up Program Cooperative Research Group. Circulation. 1984 Dec;70(6):996-1003.
•   The hypertension detection and follow-up program: Hypertension detection and follow-up program cooperative group
  Prev Med. 1976 Jun;5(2):207-15.
•   Therapeutic control of blood pressure in the Hypertension Detection and Follow-up Program
  Hypertension Detection and Follow-up Program Cooperative Group. Prev Med. 1979 Jan;8(1):2-13.
•   Tyroler HA: Race, Education and Five-Year Mortality In HDFP Stratum I Referred-care Males in Mild Hypertension: Recent Advances, Gross R and Strasser T (Eds)
  New York, Raven Press, 163- , 1983.
•   Variability of blood pressure and the results of screening in the hypertension detection and follow-up program
  J Chronic Dis. 1978;31(11):651-67.
•   Wassertheil-Smoller S, Apostolides A, Miller M, Oberman A, Thom T
  Recent status of detection, treatment, and control of hypertension in the community. J Community Health. 1979 Winter;5(2):82-93.
•   Wassertheil-Smoller S, Bell B, Blaufox MD
  Computer-aided management of hypertensive patients. Med Care. 1975 Dec;13(12):1044-54.
•   Wassertheil-Smoller S, Blaufox MD
  Planning case-finding activities for a community hypertension-control program. Bull N Y Acad Med. 1976 Jul-Aug;52(6):648-56.
•   Willett WC, Polk BF, Morris JS, Stampfer MJ, Pressel S, Rosner B, Taylor JO, Schneider K, Hames CG
  Prediagnostic serum selenium and risk of cancer. Lancet. 1983 Jul 16;2(8342):130-4.
•   Willett WC, Polk BF, Underwood BA, Stampfer MJ, Pressel S, Rosner B, Taylor JO, Schneider K, Hames CG
  Relation of serum vitamins A and E and carotenoids to the risk of cancer. N Engl J Med. 1984 Feb 16;310(7):430-4.
•   Williams WR, Schneider KA, Borhani NO, Schnaper HW, Slotkoff LM, Ellefson RD
  The relationship between diuretics and serum cholesterol in Hypertension Detection and Follow-up Program participants. Am J Prev Med. 1986 Sep-Oct;2(5):248-55.

Details for clinical trial NCT00000485